Jo
Hematology Medical Affairs Director Canada
Johnson & Johnson
Full-time
toronto, on
Management & Operations
Posted:
June 06, 2026
Location:
toronto, on, Canada
Job Description
Take charge of hematology strategies with a leading company in Toronto, Ontario. This Medical Affairs Director role focuses on execution, leadership, and cross-functional collaboration in a hybrid work model.
As the Medical Affairs Director for Hematology, you will spearhead strategy development and execution, working closely with stakeholders and experts. You'll co-lead the Patient Value Team, oversee clinical research initiatives, and ensure Canadian needs are incorporated in global strategies. Utilizing your deep experience, you will also manage teams and drive evidence generation plans while maintaining scientific expertise.
Key Responsibilities:
• Develop hematology medical strategy aligned with stakeholders
• Co-lead Patient Value Team for business planning
• Lead launch readiness for pipeline assets
• Represent Canada in global medical affairs teams
• Identify evidence gaps and develop data plans
Requirements:<...
As the Medical Affairs Director for Hematology, you will spearhead strategy development and execution, working closely with stakeholders and experts. You'll co-lead the Patient Value Team, oversee clinical research initiatives, and ensure Canadian needs are incorporated in global strategies. Utilizing your deep experience, you will also manage teams and drive evidence generation plans while maintaining scientific expertise.
Key Responsibilities:
• Develop hematology medical strategy aligned with stakeholders
• Co-lead Patient Value Team for business planning
• Lead launch readiness for pipeline assets
• Represent Canada in global medical affairs teams
• Identify evidence gaps and develop data plans
Requirements:<...
Apply for this Job
Submit your application for the Hematology Medical Affairs Director Canada position at Johnson & Johnson.
Apply Now Save for LaterJob Overview
Job Type:
Full-time
Location:
toronto, Canada
Posted:
June 06, 2026
Deadline:
July 16, 2026